{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:45Z","timestamp":1789521765459,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022H9MPZ5"],"award-info":[{"award-number":["2022H9MPZ5"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE00000003"],"award-info":[{"award-number":["PE00000003"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP D93C22000890001"],"award-info":[{"award-number":["CUP D93C22000890001"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["1550"],"award-info":[{"award-number":["1550"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CUP H93C22000430007"],"award-info":[{"award-number":["CUP H93C22000430007"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tem.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:45:10Z","timestamp":1776833110000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cholesterol\u2013LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-2689","authenticated-orcid":false,"given":"Elena","family":"Piccinin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-5321","authenticated-orcid":false,"given":"Gaetano","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-6074","authenticated-orcid":false,"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2026.03.011_bb0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2026.03.011_bb0015","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/nu13062101","article-title":"Visceral adiposity and cancer: role in pathogenesis and prognosis","volume":"13","author":"Crudele","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2026.03.011_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort\u2606","volume":"73","author":"Anstee","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2026.03.011_bb0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbalip.2013.12.006","article-title":"Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function","volume":"1841","author":"Pingitore","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2026.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2026.03.011_bb0035","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep4.1822","article-title":"TM6SF2: a novel genetic player in nonalcoholic fatty liver and cardiovascular disease","volume":"6","author":"Luo","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2026.03.011_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132158","article-title":"Hydroxysteroid 17-beta dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease","volume":"5","author":"Luukkonen","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2026.03.011_bb0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose stimulated de novo lipogenesis is promoted by inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0060","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15377","article-title":"Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals","volume":"42","author":"Saponaro","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2026.03.011_bb0065","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1858","article-title":"Pcsk9 deletion promotes murine nonalcoholic steatohepatitis and hepatic carcinogenesis: role of cholesterol","volume":"6","author":"Ioannou","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0075","article-title":"Intestinal Pgc1\u03b1 ablation protects from liver steatosis and fibrosis","volume":"5","author":"Piccinin","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0085","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmet.2025.01.020","article-title":"EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"37","author":"Ma","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12885-022-09516-1","article-title":"Activated TAZ induces liver cancer in collaboration with EGFR\/HER2 signaling pathways","volume":"22","author":"Moon","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tem.2026.03.011_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tem.2026.03.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2502978122","article-title":"Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis","volume":"122","author":"Sakuma","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2026.03.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2026.03.011_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1194\/jlr.M053785","article-title":"Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH","volume":"56","author":"Ioannou","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2026.03.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220681","article-title":"Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH","volume":"220","author":"Itoh","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2026.03.011_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.2300847","article-title":"Cutting edge: hepatic stellate cells drive the phenotype of monocyte-derived macrophages to regulate liver fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"213","author":"Chan","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2026.03.011_bb0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.tem.2026.03.011_bb0130","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/nu13062011","article-title":"Dietary patterns and hepatocellular carcinoma risk among US adults","volume":"13","author":"Moussa","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2026.03.011_bb0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/hep.31391","article-title":"Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma","volume":"73","author":"Hall","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0140","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1053\/j.gastro.2021.02.051","article-title":"Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2026.03.011_bb0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.29484","article-title":"Hepatic peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b2 drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice","volume":"67","author":"Piccinin","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/15384101.2017.1282586","article-title":"Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma","volume":"16","author":"Che","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tem.2026.03.011_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14689","article-title":"Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival","volume":"8","author":"Nelson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0160","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.tem.2026.03.011_bb0170","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","article-title":"An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming","volume":"30","author":"Liu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tem.2026.03.011_bb0175","article-title":"Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet","volume":"1869","author":"Ntambi","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.tem.2026.03.011_bb0180","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/hep4.2053","article-title":"Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma","volume":"6","author":"Ducheix","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2026.03.011_bb0190","article-title":"Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling","volume":"11","author":"Zhang","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.tem.2026.03.011_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101230","article-title":"LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK\/ERK signaling pathway","volume":"51","author":"Chen","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2025.0115","article-title":"Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease","volume":"185","author":"Choi","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.tem.2026.03.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102300","article-title":"Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study","volume":"65","author":"Jeon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.tem.2026.03.011_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cgh.2022.01.057","article-title":"Statin use and reduced hepatocellular carcinoma risk in patients with nonalcoholic fatty liver disease","volume":"21","author":"Zou","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2026.03.011_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCG.0000000000001478","article-title":"Efficacy and safety of statin for hepatocellular carcinoma prevention among chronic liver disease patients: a systematic review and meta-analysis","volume":"55","author":"Wong","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.tem.2026.03.011_bb0220","article-title":"Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis","volume":"5","author":"Crudele","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0225","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41416-019-0691-3","article-title":"Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma","volume":"122","author":"Yi","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tem.2026.03.011_bb0230","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","article-title":"High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice","volume":"158","author":"Qin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2026.03.011_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2026.03.011_bb0240","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.cellbio.16.1.459","article-title":"The role of orphan nuclear receptors in the regulation of cholesterol homeostasis","volume":"16","author":"Repa","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tem.2026.03.011_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122683119","article-title":"Integrative analysis reveals multiple modes of LXR transcriptional regulation in liver","volume":"119","author":"Bideyan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2026.03.011_bb0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25015","article-title":"Expression of SREBP-1c requires SREBP-2-mediated generation of a sterol ligand for LXR in livers of mice","volume":"6","author":"Rong","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tem.2026.03.011_bb0260","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2026.03.011_bb0265","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1172\/JCI93616","article-title":"ER phospholipid composition modulates lipogenesis during feeding and in obesity","volume":"127","author":"Rong","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2026.03.011_bb0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31170-6","article-title":"The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease","volume":"14","author":"Aguilar-Olivos","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.tem.2026.03.011_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmet.2005.03.001","article-title":"LXRs regulate the balance between fat storage and oxidation","volume":"1","author":"Kalaany","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0280","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbrc.2005.12.137","article-title":"Niemann\u2013Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine","volume":"340","author":"Duval","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0285","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1194\/jlr.M006353","article-title":"Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis","volume":"51","author":"Jia","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2026.03.011_bb0290","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1210\/en.2013-2143","article-title":"The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice","volume":"155","author":"Sugizaki","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2026.03.011_bb0295","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2017.10.003","article-title":"NRF1 is an ER membrane sensor that is central to cholesterol homeostasis","volume":"171","author":"Widenmaier","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tem.2026.03.011_bb0300","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(03)00384-8","article-title":"Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism","volume":"12","author":"Castrillo","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tem.2026.03.011_bb0305","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216845","article-title":"Inhibition of DHCR24 activates LXR\u03b1 to ameliorate hepatic steatosis and inflammation","volume":"15","author":"Zhou","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tem.2026.03.011_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107665","article-title":"Interplay between liver X receptor and hypoxia inducible factor 1\u03b1 potentiates interleukin-1\u03b2 production in human macrophages","volume":"31","author":"Menegaut","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0315","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2026.03.011_bb0320","first-page":"A1","article-title":"Abequolixron (RGX-104), a first-in-class oral immunotherapy targeting the liver-X receptor (LXR), in combination with docetaxel in recurrent advanced\/metastatic non-small cell lung cancer (NSCLC)","volume":"12","author":"Mita","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tem.2026.03.011_bb0325","article-title":"Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases","volume":"10","author":"Griffett","year":"2023","journal-title":"Front. Med. Lausanne"},{"key":"10.1016\/j.tem.2026.03.011_bb0330","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41591-025-04169-6","article-title":"An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial","volume":"32","author":"Li","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2026.03.011_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114691","article-title":"Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia","volume":"43","author":"Xue","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Lo Sasso","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0345","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.gastro.2015.11.015","article-title":"Liver X receptor regulates triglyceride absorption through intestinal down-regulation of scavenger receptor class B, type 1","volume":"150","author":"Briand","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2026.03.011_bb0350","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1111\/liv.14712","article-title":"HDL cholesterol protects from liver injury in mice with intestinal specific LXR\u03b1 activation","volume":"40","author":"Pierantonelli","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2026.03.011_bb0355","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/s42255-024-01126-4","article-title":"Damaging mutations in liver X receptor-\u03b1 are hepatotoxic and implicate cholesterol sensing in liver health","volume":"6","author":"Lockhart","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0360","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-025-56565-8","article-title":"A mutation in LXR\u03b1 uncovers a role for cholesterol sensing in limiting metabolic dysfunction-associated steatohepatitis","volume":"16","author":"Clark","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0365","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.celrep.2018.12.094","article-title":"Impaired LXR\u03b1 phosphorylation attenuates progression of fatty liver disease","volume":"26","author":"Becares","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41389-019-0140-4","article-title":"LXR\u03b1 limits TGF\u03b2-dependent hepatocellular carcinoma associated fibroblast differentiation","volume":"8","author":"Moren","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.tem.2026.03.011_bb0375","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/hep4.1880","article-title":"Chronic activation of LXR\u03b1 sensitizes mice to hepatocellular carcinoma","volume":"6","author":"Xie","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0380","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12253-017-0249-8","article-title":"Tumor LXR expression is a prognostic marker for patients with hepatocellular carcinoma","volume":"24","author":"Long","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.tem.2026.03.011_bb0385","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13578-024-01248-y","article-title":"Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma","volume":"14","author":"Piccinin","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tem.2026.03.011_bb0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00204-016-1693-z","article-title":"Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury","volume":"91","author":"Wang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tem.2026.03.011_bb0395","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2015.03.002","article-title":"Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer","volume":"21","author":"Bovenga","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.03.011_bb0400","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23436","article-title":"Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes","volume":"51","author":"Lo Sasso","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2026.03.011_bb0405","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201001","article-title":"Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tem.2026.03.011_bb0410","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2019.01.034","article-title":"SULT2B1b promotes epithelial-mesenchymal transition through activation of the \u03b2-catenin\/MMP7 pathway in hepatocytes","volume":"510","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2026.03.011_bb0415","article-title":"Clinical significance and potential mechanisms of ATP binding cassette subfamily C genes in hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.tem.2026.03.011_bb0420","first-page":"3597","article-title":"ABCC1 is a predictive biomarker for prognosis and therapy in hepatocellular carcinoma","volume":"27","author":"Han","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.tem.2026.03.011_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2019.08.002","article-title":"Liver X receptor agonism sensitizes a subset of hepatocellular carcinoma to sorafenib by dual-inhibiting MET and EGFR","volume":"22","author":"Shao","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.tem.2026.03.011_bb0430","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.gastha.2022.05.014","article-title":"In vivo screen identifies liver X receptor alpha agonism potentiates sorafenib killing of hepatocellular carcinoma","volume":"1","author":"Vazquez Salgado","year":"2022","journal-title":"Gastro. Hep. Adv."},{"key":"10.1016\/j.tem.2026.03.011_bb0435","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s43018-020-00168-3","article-title":"LXR\u03b1 activation and Raf inhibition trigger lethal lipotoxicity in liver cancer","volume":"2","author":"Rudalska","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tem.2026.03.011_bb0440","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","article-title":"Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis","volume":"28","author":"Flaveny","year":"2015","journal-title":"Cancer Cell"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:07:58Z","timestamp":1783174078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276026000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":88,"alternative-id":["S1043276026000901"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2026.03.011","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol\u2013LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}